BACKGROUND: As the Global Programme to Eliminate Lymphatic Filariasis (LF) approaches its 2020 goal, an increasing number of districts will enter the endgame phase where drug coverage rates from mass drug administration (MDA) are used to assess whether MDA can be stopped. As reported, the gap between reported and actual drug coverage in some contexts has overestimated the true rates, thus causing premature administration of transmission assessment surveys (TAS) that detect ongoing LF transmission. In these cases, districts must continue with additional rounds of MDA. Two districts in Indonesia (Agam District, Depok City) fit this criteria-one had not met the pre-TAS criteria and the other, had not passed the TAS criteria. In both cases, the...
Introduction: Mass drug administration (MDA) means once-in-a-year administration of Diethyl Carbamaz...
ABSTRACT: BACKGROUND: The World Health Organization (WHO) Global Program to Eliminate Lymphatic Fila...
Background: Mass Drug Administration of a single dose of DEC was launched on June 5, 2004 by the Gov...
As the Global Programme to Eliminate Lymphatic Filariasis (LF) approaches its 2020 goal, an increasi...
Author Summary This research describes the process used to assist two districts endemic for lymphati...
BACKGROUND: This research assesses knowledge amongst drug deliverers about the implementation of mas...
Lymphatic filariasis (LF) elimination as a public health problem requires the interruption of transm...
BACKGROUND: One challenge to achieving Lymphatic filariasis (LF) elimination is the persistent cover...
World Health Organization (WHO) initiated The Global Program to Eliminate Lymphatic Filariasis (LF) ...
Lymphatic filariasis (LF) elimination as a public health problem requires the interruption of transm...
BACKGROUND:Following the World Health Assembly resolution on Elimination of lymphatic filariasis (EL...
BACKGROUND: The success of programs to eliminate lymphatic filariasis (LF) depends in large part on ...
Lymphatic filariasis has been targeted for elimination by 2020, and a threshold of 65% coverage of m...
BACKGROUND: Guyana is one of four countries in the Latin American Region where lymphatic filariasis ...
Lymphatic filariasis (LF) elimination as a public health problem requires the interruption of transm...
Introduction: Mass drug administration (MDA) means once-in-a-year administration of Diethyl Carbamaz...
ABSTRACT: BACKGROUND: The World Health Organization (WHO) Global Program to Eliminate Lymphatic Fila...
Background: Mass Drug Administration of a single dose of DEC was launched on June 5, 2004 by the Gov...
As the Global Programme to Eliminate Lymphatic Filariasis (LF) approaches its 2020 goal, an increasi...
Author Summary This research describes the process used to assist two districts endemic for lymphati...
BACKGROUND: This research assesses knowledge amongst drug deliverers about the implementation of mas...
Lymphatic filariasis (LF) elimination as a public health problem requires the interruption of transm...
BACKGROUND: One challenge to achieving Lymphatic filariasis (LF) elimination is the persistent cover...
World Health Organization (WHO) initiated The Global Program to Eliminate Lymphatic Filariasis (LF) ...
Lymphatic filariasis (LF) elimination as a public health problem requires the interruption of transm...
BACKGROUND:Following the World Health Assembly resolution on Elimination of lymphatic filariasis (EL...
BACKGROUND: The success of programs to eliminate lymphatic filariasis (LF) depends in large part on ...
Lymphatic filariasis has been targeted for elimination by 2020, and a threshold of 65% coverage of m...
BACKGROUND: Guyana is one of four countries in the Latin American Region where lymphatic filariasis ...
Lymphatic filariasis (LF) elimination as a public health problem requires the interruption of transm...
Introduction: Mass drug administration (MDA) means once-in-a-year administration of Diethyl Carbamaz...
ABSTRACT: BACKGROUND: The World Health Organization (WHO) Global Program to Eliminate Lymphatic Fila...
Background: Mass Drug Administration of a single dose of DEC was launched on June 5, 2004 by the Gov...